ADJUSTMENT DISORDER
Clinical trials for ADJUSTMENT DISORDER explained in plain language.
Never miss a new study
Get alerted when new ADJUSTMENT DISORDER trials appear
Sign up with your email to follow new studies for ADJUSTMENT DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
One-Dose hope: new drug targets emotional toll of cancer and chronic disease
Symptom relief Recruiting nowThis study tests whether a single injection of RE104 can reduce depression and anxiety symptoms in people with adjustment disorder caused by cancer, ALS, multiple sclerosis, Parkinson's disease, or idiopathic pulmonary fibrosis. About 100 participants will receive either a higher…
Matched conditions: ADJUSTMENT DISORDER
Phase: PHASE2 • Sponsor: Reunion Neuroscience Inc • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC
-
Virtual reality headsets tested to calm cancer patients during treatment
Symptom relief Recruiting nowThis study tests whether using virtual reality (VR) headsets is safe and helpful for cancer patients who feel anxious, depressed, or stressed during treatment. About 24 patients will use VR to explore calming scenes like forests or oceans. The goal is to see if this can improve t…
Matched conditions: ADJUSTMENT DISORDER
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 22, 2026 13:51 UTC
-
Magic mushroom therapy targets Cancer-Related anxiety in new trial
Symptom relief Recruiting nowThis study tests whether a drug called NPX-5 (psilocybin) combined with talk therapy can reduce severe anxiety in people who have been diagnosed with cancer. About 87 adults aged 18 to 80 will receive one of three doses (25 mg, 10 mg, or 1 mg) during an 8-hour therapy session. Th…
Matched conditions: ADJUSTMENT DISORDER
Phase: PHASE2 • Sponsor: Psyence Australia Pty Ltd • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC